A retrospective, observational, cohort study done to assess
whether a diagnosis of a schizophrenia spectrum disorder, mood
disorder, or anxiety disorder is associated with mortality in
patients with COVID-19.
About the Podcast
Season-3 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.